Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / FOLD - Amicus Therapeutics: The Pompe Data Slump Was An Overreaction

FOLD - Amicus Therapeutics: The Pompe Data Slump Was An Overreaction

Amicus Therapeutics Inc.
  • Amicus produced mixed results in the PROPEL trial.
  • However, it has a high chance of approval on data from this and earlier trials.
  • Its Galafold franchise is progressing strongly.

For further details see:

Amicus Therapeutics: The Pompe Data Slump Was An Overreaction
Stock Information
Company Name: Amicus Therapeutics Inc.
Stock Symbol: FOLD
Market: NASDAQ
Website: amicusrx.com
Menu
FOLD FOLD Quote FOLD Short FOLD News FOLD Articles FOLD Message Board
Get FOLD Alerts

News, Short Squeeze, Breakout and More Instantly...